These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 16452992

  • 1. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice.
    Guilloux JP, David DJ, Guiard BP, Chenu F, Repérant C, Toth M, Bourin M, Gardier AM.
    Neuropsychopharmacology; 2006 Oct; 31(10):2162-72. PubMed ID: 16452992
    [Abstract] [Full Text] [Related]

  • 2. Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice.
    Guiard BP, Przybylski C, Guilloux JP, Seif I, Froger N, De Felipe C, Hunt SP, Lanfumey L, Gardier AM.
    J Neurochem; 2004 Apr; 89(1):54-63. PubMed ID: 15030389
    [Abstract] [Full Text] [Related]

  • 3. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T, Umbers V, Gartside SE.
    Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
    [Abstract] [Full Text] [Related]

  • 4. Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study.
    Míguez JM, Paz-Valiñas L, Míguez I, Aldegunde M.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):378-87. PubMed ID: 12012024
    [Abstract] [Full Text] [Related]

  • 5. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
    Gobert A, Millan MJ.
    Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
    [Abstract] [Full Text] [Related]

  • 6. Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study.
    Gartside SE, Clifford EM, Cowen PJ, Sharp T.
    Br J Pharmacol; 1999 May; 127(1):145-52. PubMed ID: 10369467
    [Abstract] [Full Text] [Related]

  • 7. In vivo efflux of serotonin in the dorsal raphe nucleus of 5-HT1A receptor knockout mice.
    Bortolozzi A, Amargós-Bosch M, Toth M, Artigas F, Adell A.
    J Neurochem; 2004 Mar; 88(6):1373-9. PubMed ID: 15009637
    [Abstract] [Full Text] [Related]

  • 8. Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors.
    Romero L, Artigas F.
    J Neurochem; 1997 Jun; 68(6):2593-603. PubMed ID: 9166757
    [Abstract] [Full Text] [Related]

  • 9. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C, Seyfried CA.
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [Abstract] [Full Text] [Related]

  • 10. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.
    Scott C, Soffin EM, Hill M, Atkinson PJ, Langmead CJ, Wren PB, Faedo S, Gordon LJ, Price GW, Bromidge S, Johnson CN, Hagan JJ, Watson J.
    Eur J Pharmacol; 2006 Apr 24; 536(1-2):54-61. PubMed ID: 16571351
    [Abstract] [Full Text] [Related]

  • 11. Acute 5-HT₁A autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions.
    Ferrés-Coy A, Santana N, Castañé A, Cortés R, Carmona MC, Toth M, Montefeltro A, Artigas F, Bortolozzi A.
    Psychopharmacology (Berl); 2013 Jan 24; 225(1):61-74. PubMed ID: 22820867
    [Abstract] [Full Text] [Related]

  • 12. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
    Arborelius L, Nomikos GG, Hertel P, Salmi P, Grillner P, Höök BB, Hacksell U, Svensson TH.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May 24; 353(6):630-40. PubMed ID: 8738296
    [Abstract] [Full Text] [Related]

  • 13. Sustained pharmacological blockade of NK1 substance P receptors causes functional desensitization of dorsal raphe 5-HT 1A autoreceptors in mice.
    Guiard BP, Froger N, Hamon M, Gardier AM, Lanfumey L.
    J Neurochem; 2005 Dec 24; 95(6):1713-23. PubMed ID: 16219031
    [Abstract] [Full Text] [Related]

  • 14. Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT.
    Gartside SE, Umbers V, Hajós M, Sharp T.
    Br J Pharmacol; 1995 Jul 24; 115(6):1064-70. PubMed ID: 7582504
    [Abstract] [Full Text] [Related]

  • 15. Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain.
    Romero L, Bel N, Artigas F, de Montigny C, Blier P.
    Neuropsychopharmacology; 1996 Oct 24; 15(4):349-60. PubMed ID: 8887989
    [Abstract] [Full Text] [Related]

  • 16. Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms.
    Redrobe JP, Bourin M, Colombel MC, Baker GB.
    J Psychopharmacol; 1998 Oct 24; 12(4):348-55. PubMed ID: 10065908
    [Abstract] [Full Text] [Related]

  • 17. Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice.
    Gardier AM, David DJ, Jego G, Przybylski C, Jacquot C, Durier S, Gruwez B, Douvier E, Beauverie P, Poisson N, Hen R, Bourin M.
    J Neurochem; 2003 Jul 24; 86(1):13-24. PubMed ID: 12807420
    [Abstract] [Full Text] [Related]

  • 18. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA.
    Eur J Pharmacol; 2005 Mar 07; 510(1-2):49-57. PubMed ID: 15740724
    [Abstract] [Full Text] [Related]

  • 19. 5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization.
    Froger N, Gardier AM, Moratalla R, Alberti I, Lena I, Boni C, De Felipe C, Rupniak NM, Hunt SP, Jacquot C, Hamon M, Lanfumey L.
    J Neurosci; 2001 Oct 15; 21(20):8188-97. PubMed ID: 11588191
    [Abstract] [Full Text] [Related]

  • 20. Loss of Adult 5-HT1A Autoreceptors Results in a Paradoxical Anxiogenic Response to Antidepressant Treatment.
    Turcotte-Cardin V, Vahid-Ansari F, Luckhart C, Daigle M, Geddes SD, Tanaka KF, Hen R, James J, Merali Z, Béïque JC, Albert PR.
    J Neurosci; 2019 Feb 20; 39(8):1334-1346. PubMed ID: 30552180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.